6
PYFA0312.TXT

PYFA
Pyridam Farma Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Dec-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 12

Summary of Balance Sheet
  Receivables               :       4,722,614.97
  Inventories               :       5,487,350.23
  Current Assets            :      11,736,999.02
  Fixed Assets              :      56,314,302.82
  Other Asstes              :               0.00
  Total Assets              :      68,267,469.76
  Current Liabilities       :       7,306,847.88
  Longterm Liabiities       :         249,467.87
  Total Liabilities         :       7,556,315.75
  Authorized                :       1,600,000.00
  Paid-up Capital           :      53,508,000.00
  Par Value                 :                100
  Paid-up Capital Shares    :         535,080.00
  Retained Earnings         :       5,138,075.51
  Total Equity              :      60,711,154.01
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :      27,256,241.45
  Cost of Good Sold         :      10,263,019.99
  Gross Profit              :      16,993,221.46
  Operating Profit          :       1,852,096.00
  Other Income              :        -504,695.37
  Eearning Before Tax       :       1,347,400.63
  Tax                       :         728,693.13
  Net Income                :         618,707.50
  Closing Price             :              80.00

Per Share Data (Rp)
  Eps                       :               1.16
  Book Value                :             113.46

Financial Ratios
  Debt Equity Ratio (X)     :                .12
  Roa (%)                   :                .91
  Roe (%)                   :               1.02
  Npm (%)                   :               2.27
  Opm (%)                   :               6.80

Cash Flow
  CF from Operating Activities                        :       3,288,915.99
  CF from Investing Activities                        :        -581,556.26
  CF from Financing Activities                        :      -2,918,145.39
  Net Increase in Cash & Cash Equivalent              :        -210,785.66
  Cash & Cash Equivalent at The Beginning of The Year :         831,256.76
  Cash & Cash Equivalent at The End of The Year       :         620,471.10

 
 
 
